Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta-1a
- Publication date
- 11 March 2022
- Publisher
- 'Royal College of Obstetricians & Gynaecologists (RCOG)'